<DOC>
	<DOCNO>NCT02058524</DOCNO>
	<brief_summary>The investigator conduct open-label study fecal microbiota transplantation ( FMT ) adult patient mildly-moderately active ulcerative colitis . In pilot study investigator evaluate feasibility , safety , tolerability single application FMT deliver colonoscopically . The investigator also characterize impact FMT microbiota recipient determine correlate microbiota FMT donor .</brief_summary>
	<brief_title>A Pilot Feasibility Study Fecal Microbiota Transplantation Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Men woman , age 1865 year old Prior endoscopic confirmation UC : Mildly moderately active UC Simple Clinical Colitis Activity Index ( SCCAI ) activity index &gt; 49 Failing standard therapy : stable dos 5ASA &gt; 2 week ; thiopurines &gt; 3 month ; steroid dependent dose &lt; 20mg/d ; ( inability taper steroid longer 1 week ) Stable medication dose least 2 week prior screen upon entry trial Ability understand willingness sign inform consent document Diagnosis Crohn 's disease , indeterminate colitis , proctitis alone Severe fulminate colitis Women pregnant nursing Patients unable give inform consent Patients unable unwilling undergo colonoscopy Patients previously undergone FMT Patients confirm malignancy cancer Patients immunocompromised Treatment within last 12 week cyclosporine , tacrolimus , infliximab , adalimumab , certolizumab , natalizumab , thalidomide Antibiotic use within 2months start date Participation clinical trial precede 30 day simultaneously trial Probiotic use within 30 day start date Rectal therapy within 14 day start date Decompensated cirrhosis Congenital acquire immunodeficiency Other comorbidities include : Diabetes mellitus , cancer , systemic lupus , must able tolerate conscious sedation colonoscopy Chronic kidney disease define GFR &lt; 60mL/min/1.73m2 ( 40 ) History rheumatic heart disease , endocarditis , valvular disease due risk bacteremia . Steroid &gt; 20mg/day Positive screen confirmatory test HIV 1 &amp; 2 , Hepatitis A , B , &amp; C , Syphilis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Ulcerative Colitis</keyword>
	<keyword>Fecal Microbiota Transplantation</keyword>
</DOC>